Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2006 Jul;20(8):873-84; discussion 886-8, 893-5.

Radiation therapy in the treatment of cholangiocarcinoma

Affiliations
  • PMID: 16922259
Free article
Review

Radiation therapy in the treatment of cholangiocarcinoma

Brian G Czito et al. Oncology (Williston Park). 2006 Jul.
Free article

Abstract

The prognosis of patients with biliary cancers is poor. Although surgery is potentially curative in selected patients, local recurrence is a common pattern of failure. Adjuvant or neoadjuvant radiation therapy improves local control and possibly survival. In locally advanced patients, radiation therapy provides palliation and may prolong survival. Concurrently administered chemotherapy may further enhance these results. Newer radiation therapy techniques, including intraluminal transcatheter brachytherapy, intraoperative radiation therapy, intensity-modulated radiation therapy, and three- and four-dimensional treatment planning, permit radiation dose escalation without significant increases in normal tissue toxicity, thereby increasing the effective radiation dose. Preliminary results of studies employing hepatic transplantation with radiation therapy are encouraging. Although these new approaches hold promise, the prognosis in patients with biliary cancers remains poor, and the integration of novel therapeutic strategies is indicated.

PubMed Disclaimer

Similar articles

Cited by

  • Cholangiocarcinoma--controversies and challenges.
    Patel T. Patel T. Nat Rev Gastroenterol Hepatol. 2011 Apr;8(4):189-200. doi: 10.1038/nrgastro.2011.20. Nat Rev Gastroenterol Hepatol. 2011. PMID: 21460876 Free PMC article. Review.
  • NCCN clinical practice guidelines in oncology: hepatobiliary cancers.
    Benson AB 3rd, Abrams TA, Ben-Josef E, Bloomston PM, Botha JF, Clary BM, Covey A, Curley SA, D'Angelica MI, Davila R, Ensminger WD, Gibbs JF, Laheru D, Malafa MP, Marrero J, Meranze SG, Mulvihill SJ, Park JO, Posey JA, Sachdev J, Salem R, Sigurdson ER, Sofocleous C, Vauthey JN, Venook AP, Goff LW, Yen Y, Zhu AX. Benson AB 3rd, et al. J Natl Compr Canc Netw. 2009 Apr;7(4):350-91. doi: 10.6004/jnccn.2009.0027. J Natl Compr Canc Netw. 2009. PMID: 19406039 Free PMC article. No abstract available.
  • Eastern Canadian Gastrointestinal Cancer Consensus Conference 2019.
    Gotfrit J, Goodwin R, Asmis T, Hyde AJ, Alcindor T, Aubin F, Berry S, Bossé D, Brown C, Burkes R, Burnell M, Colwell B, Corbett J, Craswell J, Daaboul N, Doherty M, Fleming DAB, Galvis L, Goel R, Harb M, Jeyakumar A, Jonker D, Kennedy E, Lock M, Mahmud A, McCrea PH, Nair V, Nassabein R, Nessim C, Ramjeesingh R, Raza M, Saliba W, Samimi S, Singh S, Snow S, Tehfé M, Thirlwell M, Valdes M, Welch S, Vickers M. Gotfrit J, et al. Curr Oncol. 2021 May 26;28(3):1988-2006. doi: 10.3390/curroncol28030185. Curr Oncol. 2021. PMID: 34073199 Free PMC article.
  • Resectable Cholangiocarcinoma: Reviewing the Role of Adjuvant Strategies.
    Cidon EU. Cidon EU. Clin Med Insights Oncol. 2016 May 12;10:43-8. doi: 10.4137/CMO.S32821. eCollection 2016. Clin Med Insights Oncol. 2016. PMID: 27199577 Free PMC article. Review.
  • Emerging molecular targets and therapy for cholangiocarcinoma.
    Kayhanian H, Smyth EC, Braconi C. Kayhanian H, et al. World J Gastrointest Oncol. 2017 Jul 15;9(7):268-280. doi: 10.4251/wjgo.v9.i7.268. World J Gastrointest Oncol. 2017. PMID: 28808500 Free PMC article. Review.

Publication types

LinkOut - more resources